Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 5, 1996, Pages 927-932

  Strickland, Paul ^a   Kang, Daehee ^a,b   Sithisarankul, Pornchai ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Seoul National University   (South Korea)

Author keywords

1 hydroxypyrene; Benzo a pyrene tetrol; Exposure biomarker; Internal dose; Polycyclic aromatic hydrocarbons; Urinary metabolites

Indexed keywords

3 HYDROXYBENZO[A]PYRENE; BETA GLUCURONIDASE; POLYCYCLIC AROMATIC HYDROCARBON;

CONFERENCE PAPER; ENVIRONMENTAL HEALTH; HUMAN; METABOLITE; NONHUMAN; PRIORITY JOURNAL; URINE;

EID: 0029831684     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s5927     Document Type: Conference Paper

References (52)

1. Baum EJ. Occurrence and surveillance of polycyclic aromatic hydrocarbons. In: Polycyclic Hydrocarbons and Cancer, Vol 1 (Gelboin HV and Ts'o POP, eds). New York:Academic Press, 1978;45-70.
2. Sontag JM. Carcinogens in Industry and the Environment. New York:Marcel Dekker, 1981;167-281;467-475.
3. IARC. Evaluation of the carcinogenic risk of chemicals to humans: polynuclear aromatic compounds, Part 1. IARC Monograph No 35. Lyon:International Agency for Research on Cancer, 1983.
4. Bjørseth A, Becher G. Biological monitoring of PAH exposure. In: PAH in Work Atmospheres: Occurrence and Determination. Boca Raton, FL:CRC Press, 1986.
5. Lioy PJ, Waldman JM, Greenberg A, Harkov R, Pietarinen C. The total human environmental exposure study (THEES) to benzo[a]pyrene: comparison of the inhalation and food pathways. Arch Env Health 43:304-312, 1988.
6. WHO. Guidelines for Drinking Water Quality. Vol 1: Recommendations. Geneva:World Health Organization, 1984;130.
7. Lijinsky W, Shubik P. Benzo[a]pyrene and other polynuclear hydrocarbonsin charcoal-broiled meat. Science 145:53-55 (1964).
8. Fazio T, Howard JW. Polycyclic aromatic hydrocarbons in foods. In: Handbook of Poylycyclic Aromatic Hydrocarbons, Vol 1 (Bjørseth A, ed). New York:Marcel Dekker, 1983;461-505.
9. IARC. Evaluation of the carcinogenic risk of chemicals to man: certain polycyclic aromatic hydrocarbons and heterocyclic components. IARC Monograph No 3. Lyon:International Agency for Research on Cancer, 1973:91-136.
10. IARC. Evaluation of the carcinogenic risk of chemicals to humans: polynuclear aromatic compounds, Part 1. IARC Monograph No 34. Lyon:International Agency for Research on Cancer, 1984.
11. IARC. Evaluation of the carcinogenic risk of chemicals to humans: polynuclear aromatic compounds, Part 4. IARC Monograph No 35. Lyon:International Agency for Research on Cancer, 1985.
12. IARC. Evaluation of the carcinogenic risk of chemicals to humans: overall evaluations of carcinogenicity. IARC Monograph Supp 7. Lyon:International Agency for Research on Cancer, 1987.
13. Armstrong BG, Tremblay CG, Cyr D, Theriault GP. Estimating the relationship between exposure to tar volatiles and the incidence of bladder cancer in aluminum smelter workers. Scand J Work Environ Health 12:486-493, 1986.
14. Schulte PA, Perera FP. Molecular Epidemiology: Principles and Practices. San Diego:Academic Press, 1993.
15. Becher G, Bjørseth A. Determination of exposure to polycyclic aromatic hydrocarbons by analysis of human urine. Cancer Lett 17:301-311 (1983).
16. Becher G, Haugen A, Bjørseth A. Multimethod determination of occupational exposute to polycyclic aromatic hydrocarbons in an aluminum plant. Carcinogenesis 5:647-651 (1984).
17. Lenier P, Clonfero E, Cottica D, Gava C, Zordan M, Pozzoli L, Levis AG. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of workers exposed to coal tar pitch volatiles in an anode plant. Carcinogenesis 6:749-752 (1985).
18. Haugen A, Becher G, Bemestad C, Vahakangas K, Trivers GE, Newman MJ, Harris CC. Determination of polycyclic hydrocarbons in the urine, benzo[a]pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Research 46:4178-4183 (1986).
19. Keimig SD, Kirby KW, Morgan DP, Keiser JE, Hubert TD. Identification of l-hydroxypyrene as a major metabolite of pyrene in pig urine. Xenobiotica 13:415-420 (1983).
20. Jongeneelen FJ, Anzion RBM, Leijdekkers CM, Bos R, Henderson PT. l-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product. Int Arch Occup Environ Health 57:47-55 (1985).
21. Jongeneelen FJ, Azion RBM, Henderson PT. Determination of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. J Chromatog 413:227-232 (1987).
22. Jongeneelen FJ, Bos RP, Anzion RBM, Theuws JLG, Henderson PT. Biological monitoring of polycyclic aromatic hydrocarbons. Scand J Work Environ Health 12:137-143 (1986).
23. Jongeneelen FJ, Anzion RBM, Scheepers PTJ, Bos RP, Henderson PT, Nijenhuis EH, Veenstra SJ, Brouns RME, Winkes A. I-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann Occup Hygiene 32:35-43 (1988).
24. Jongeneelen FJ, van Leeuwen FE, Oosterink S, Anzion RBM, van der Loop F, Bos RP, van Veen HG. Ambient and biological monitoring of cokeoven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons. Br J Ind Med 47:454-461 (1990).
25. Jongeneelen FJ, Leijdekkers CM, Henderson PT. Urinary excretion of 3-hydroxybenzo[a]pyrene after percutaneous penetration and oral absorption of benzo[a]pyrene in rats. Cancer Lett 25:195-201 (1984).
26. Clonfero E, Zordan M, Venier P, Paleologo M, Levis AG, Cottica D, Pozzoli L, Jongeneelen FJ, Bos RP, Anzion RBM. Biological monitoring of human exposure to coal tar: urinary excretion of PAHs, 1-hydroxypyrene and mutagens in psoriatic patients. Int Arch Occup Environ Health 61:363-368 (1989).
27. Strickland PT, Kang DH, Bowman ED, Fitzwilliam A, Downing TE, Rothman N, Groopman JD, Weston A. Identification of 1-hydroxypyrene as the major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis 15:483-487 (1994).
28. Gomes M, Santella RM. Immunologic methods for the detection of benzo[a]pyrene metabolites in urine. Chem Res Toxicol 3:307-310 (1990).
29. Weston A, Bowmen ED, Carr P, Rothman N, Strickland PT. Detection of metabolites of polycyclic aromatic hydrocarbons in human urine. Carcinogenesis 14:1053-1055 (1993).
30. Grimmer G, Dettbarn G, Naujack KW, Jacob J. Intake and excretion of polycyclic aromatic hydrocarbons of the masses 178, 202, 228 and 252 in the urine of coke workers compared to non-exposed workers. Intern J Environ Anal Chem 43:177-186 (1991).
31. Tolos WP, Shaw PB, Lowry LK, MacKenzie BA, Deng J, Markel HL. 1-Pyrenol: a biomarker for occupational exposure to polycyclic aromatic hydrocarbons. Appl Occup Environ Hyg 5:303-309 (1990).
32. Sherson D, Sigsgaard T, Overgaard E, Loft S, Poulsen HE, Jongeneelen FJ. Interaction of smoking, uptake of polycyclic aromatic hydrocarbons, and cytochrome P450IA2 activity among foundry workers. Br J Ind Med 49:197-202 (1992).
33. Kang DH, Rothman N, Cho SH, Lim HS, Kwon HJ, Kim SM, Schwartz BS, Strickland PT. Association of polycyclic aromatic hydrocarbon exposure estimated from job category with concentration of 1-hydroxypyrene-glucuronide in urine from steel plant workers. Occup Environ Med 52:593-599 (1995).
34. Buckley TJ, Lioy PJ. An examination of the time course from human dietary exposure to polycyclic aromatic hydrocarbons to urinary elimination of 1-hydroxypyrene. Br J Ind Med 49:113-124 (1992).
35. Kang DH, Rothman N, Poirier MC, Greenberg A, Hsu CH, Schwartz BS, Baser ME, Weston A, Groopman JD, Strickland PT. Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. Carcinogenesis 16:1079-1085 (1995).
36. Buchet JP, Gennart JP, Mercado-Calderon F, Delavignette JP, Cupers L, Lauwerys R. Evaluation of exposure to PAH in a coke production and graphite electrode manufacturing plant. Br J Ind Med 49:761-768 (1992).
37. van Maanen JMS, Moonen EJC, Maas LM, Kleinjans JCS, van Schooten FJ. Formation of aromatic DNA adducts in white blood cells in relation to urinary excretion of 1-hydroxypyrene during consumption of grilled meat. Carcinogenesis 15:2263-2268 (1994).
38. Boyland E, Sims P. Metabolism of polycyclic compounds: 23. The metabolism of pyrene in rats and rabbits. Biochem J 90:391-398 (1964).
39. Kotin P, Fal. 3,4-Benzpyrene after administration to mice and rats. J Natl Cancer Inst 23:541-555 (1959).
40. Chipman JK, Hirom PC, Frost GS, Millburn P. The biliary excretion and enterohepatic circulation of benzo[a]pyrene and its metabolites in the rat. Biochem Pharmacol 30:937-944 (1981).
41. Chipman JK, Bhave NA, Hirom PC, Millburn P. Metabolism and excretion of benzo[a]pyrene in the rabbit. Xenobiotica 12:397-404 (1982).
42. Camus AM, Aitio A, Sabadie N, Wahrendorf J, Bartsch H. Metabolism and urinary excretion of mutagenic metabolites of benzo[a]pyrene in C57 and DBA mice strains. Carcinogenesis 5:35-39 (1984).
43. Jongeneelen FJ, Leijdekkers CM, Bos RP, Theuws JLG, Henderson PT. Excretion of 3-hydroxy-benzo[a]pyrene and mutagenicity in rat urine after exposure to benzo[a]pyrene. J Appl Tox 5:277-282 (1985).
44. Likhachev AJ, Beniashvili DS, Bykov VJ, Dikun PP, Tyndyk ML, Savochkina IV, Yermilov VB, Zabezhinski MA. Biomarkers of individual susceptibility to carcinogenic agents: Excretion and carcinogenic risk of benzo[a]pyrene metabolites. Environ Health Perspect 98:211-214 (1992).
45. Santella RM, Hemminki K, Tang DL, Paik M, Ottman R, Young TL, Savela K, Vodickova L, Dickey C, Whyatt R, Perera FP. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biomark Preven 2:59-62 (1993).
46. van Schooten FJ, Jongeneelen FJ, Hillebrand MJX, Van Leeuwen FE, de Looff AJA, Dijkmans APG, van Rooij JGM, den Engelse L, Kriek E. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cell DNA and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking. Cancer Epidemiol Biomarkers Preven 4:69-77 (1995).
47. Gaylor DW, Kadlubar FF, Beland FA. Application of biomarkers to risk assessment. Environ Health Perspect 98:139-141 (1992).
48. Jongeneelen FJ. Biological exposure limit for occupational exposure to coal tar pitch volatiles at cokeovens. Int Arch Occup Environ Health 63:511-516 (1992).
49. Groopman JD, Zhu J, Donahue PR, Pikul A, Zhang L, Chen JS, Wogan GN. Molecular dosimetry of urinary aflatoxin DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China, Cancer Res 52:45-52 (1992).
50. Rothman N, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomark Preven 4:301-311 (1995).
51. Ross R, Yuan JM, Yu M, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943-946 (1992).
52. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomark Preven 3:3-10 (1994).